
Tradename | Company | Number | Date | Products |
|---|---|---|---|---|
| VI-TWEL | Bayer | N-007012 DISCN | 1982-01-01 | 1 products |
| RUBIVITE | Bel-Mar Laboratories | N-010791 DISCN | 1982-01-01 | 5 products |
| RUBRAMIN PC | Bristol Myers Squibb | N-006799 DISCN | 1982-01-01 | 3 products, RLD |
| CALOMIST | Endo | N-022102 DISCN | 2007-07-27 | 1 products |
| NASCOBAL | Endo | N-019722 DISCN | 1996-11-05 | 1 products |
| NASCOBAL | Endo | N-021642 DISCN | 2005-01-31 | 1 products, RLD |
| REDISOL | Merck & Co | N-006668 DISCN | 1982-01-01 | 1 products |
| BERUBIGEN | Pharmacia & Upjohn | N-006798 DISCN | 1982-01-01 | 1 products |
| CYANOCOBALAMIN | Warner Chilcott | N-007085 DISCN | 1982-01-01 | 1 products |
Tradename | Company | Number | Date | Products |
|---|---|---|---|---|
| DICOPAC KIT | GE Healthcare | N-017406 DISCN | 1982-01-01 | 1 products |
Tradename | Company | Number | Date | Products |
|---|---|---|---|---|
| DEPINAR | Armour Pharmaceutical | N-011208 DISCN | 1982-01-01 | 1 products |
Brand Name | Status | Last Update |
|---|---|---|
| animi-3 | unapproved drug other | 2013-02-06 |
| animi-3 with vitamin d | unapproved drug other | 2011-05-23 |
| bacmin | unapproved drug other | 2014-05-02 |
| bal-care dha | unapproved drug other | 2012-05-01 |
| bal-care dha essential | unapproved drug other | 2012-05-01 |
| bp vit 3 | unapproved drug other | 2025-02-13 |
| c-nate dha | unapproved drug other | 2024-01-22 |
| centratex | unapproved drug other | 2024-01-31 |
| chromagen | unapproved drug other | 2026-04-08 |
| citranatal bloom dha | unapproved drug other | 2020-04-06 |

Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Vitamin b 12 deficiency | D014806 | EFO_0000734 | E53.8 | 2 | 4 | 2 | 5 | 49 | 60 |
| Anemia | D000740 | EFO_0004272 | D64.9 | — | 4 | 9 | 6 | 37 | 54 |
| Malnutrition | D044342 | EFO_0008572 | E40-E46 | — | 2 | 4 | 3 | 17 | 25 |
| Diabetes mellitus | D003920 | EFO_0000400 | E08-E13 | — | 2 | 2 | 3 | 11 | 18 |
| Cognitive dysfunction | D060825 | — | G31.84 | 1 | 4 | — | 1 | 12 | 18 |
| Iron deficiencies | D000090463 | — | E61.1 | — | 1 | 2 | 2 | 14 | 18 |
| Inflammation | D007249 | MP_0001845 | — | 2 | — | — | 1 | 14 | 17 |
| Hyperhomocysteinemia | D020138 | — | — | — | 1 | 2 | 1 | 13 | 17 |
| Diabetic neuropathies | D003929 | EFO_1000783 | — | 1 | 3 | 2 | 1 | 10 | 16 |
| Type 2 diabetes mellitus | D003924 | EFO_0001360 | E11 | — | 3 | 1 | 1 | 12 | 16 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Non-small-cell lung carcinoma | D002289 | — | — | 1 | 15 | 10 | — | 3 | 27 |
| Avitaminosis | D001361 | EFO_0005878 | E56.9 | — | 2 | 4 | — | 13 | 17 |
| Covid-19 | D000086382 | — | U07.1 | 2 | 2 | 3 | — | 9 | 15 |
| Parkinson disease | D010300 | EFO_0002508 | G20 | — | 1 | 1 | — | 10 | 11 |
| Depression | D003863 | — | F33.9 | — | 3 | 1 | — | 8 | 11 |
| Pregnancy | D011247 | EFO_0002950 | Z33.1 | 1 | — | 2 | — | 8 | 11 |
| Lung neoplasms | D008175 | — | C34.90 | 1 | 9 | 2 | — | — | 10 |
| Peripheral nervous system diseases | D010523 | — | G64 | 1 | 3 | 1 | — | 5 | 9 |
| Autistic disorder | D001321 | EFO_0003758 | F84.0 | — | 2 | 2 | — | 7 | 9 |
| Alzheimer disease | D000544 | EFO_0000249 | F03 | — | 1 | 1 | — | 6 | 8 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Healthy volunteers/patients | — | — | — | 2 | 3 | — | — | 11 | 15 |
| Recurrence | D012008 | — | — | 6 | 5 | — | — | — | 9 |
| Brain injuries | D001930 | — | S06.9 | 2 | 1 | — | — | 4 | 6 |
| Fibromyalgia | D005356 | EFO_0005687 | M79.1 | 2 | 1 | — | — | 3 | 5 |
| Systemic lupus erythematosus | D008180 | EFO_0002690 | M32 | — | 1 | — | — | 3 | 4 |
| Hepatitis | D006505 | — | K75.9 | — | 3 | — | — | 1 | 4 |
| Hepatitis a | D006506 | EFO_0007305 | B15 | — | 3 | — | — | 1 | 4 |
| Autism spectrum disorder | D000067877 | — | F84.0 | — | 1 | — | — | 3 | 4 |
| Ulcerative colitis | D003093 | EFO_0000729 | K51 | 1 | 2 | — | — | 1 | 4 |
| Memory disorders | D008569 | — | — | — | 1 | — | — | 3 | 4 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Hypertension | D006973 | EFO_0000537 | I10 | 1 | — | — | — | 4 | 5 |
| Child development | D002657 | — | — | 1 | — | — | — | 3 | 4 |
| Heart failure | D006333 | EFO_0003144 | I50 | 1 | — | — | — | 3 | 4 |
| Colorectal neoplasms | D015179 | — | — | 1 | — | — | — | 2 | 3 |
| Sezary syndrome | D012751 | — | C84.1 | 2 | — | — | — | — | 2 |
| Mycosis fungoides | D009182 | — | C84.0 | 2 | — | — | — | — | 2 |
| T-cell lymphoma cutaneous | D016410 | — | C84.A | 2 | — | — | — | — | 2 |
| Bone fractures | D050723 | EFO_0003931 | T14.8 | 1 | — | — | — | 1 | 2 |
| Multiple sclerosis | D009103 | EFO_0003885 | G35 | 1 | — | — | — | 1 | 2 |
| Cognition disorders | D003072 | — | — | 1 | — | — | — | 1 | 2 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Folic acid deficiency | D005494 | EFO_0001070 | E53.8 | — | — | — | — | 12 | 12 |
| Deglutition disorders | D003680 | — | R13.1 | — | — | — | — | 9 | 9 |
| Gyrate atrophy | D015799 | — | — | — | — | — | — | 6 | 6 |
| Metabolic syndrome | D024821 | EFO_0000195 | E88.810 | — | — | — | — | 6 | 6 |
| Vitamin a deficiency | D014802 | EFO_1001237 | E50 | — | — | — | — | 6 | 6 |
| Gastroesophageal reflux | D005764 | EFO_0003948 | K21 | — | — | — | — | 6 | 6 |
| Fatigue | D005221 | — | R53.83 | — | — | — | — | 5 | 5 |
| Wounds and injuries | D014947 | — | T14.8 | — | — | — | — | 4 | 4 |
| Nutritional status | D009752 | — | — | — | — | — | — | 4 | 4 |
| Metabolic diseases | D008659 | EFO_0000589 | E88.9 | — | — | — | — | 4 | 4 |
| Drug common name | Cyanocobalamin |
| INN | cyanocobalamin |
| Description | Cyanocobalamin is a form of vitamin B12 used to treat vitamin B12 deficiency except in the presence of cyanide toxicity. The deficiency may occur in pernicious anemia, following surgical removal of the stomach, with fish tapeworm, or due to bowel cancer. It is less preferred than hydroxocobalamin for treating vitamin B12 deficiency. Some study have shown that it has an antihypotensive effect. It is used by mouth, by injection into a muscle, or as a nasal spray.
|
| Classification | Small molecule |
| Drug class | — |
| Image (chem structure or protein) | ![]() |
| Structure (InChI/SMILES or Protein Sequence) | — |
| PDB | — |
| CAS-ID | 68-19-9 |
| RxCUI | — |
| ChEMBL ID | CHEMBL2110563 |
| ChEBI ID | — |
| PubChem CID | 16212801 |
| DrugBank | DB00115 |
| UNII ID | P6YC3EG204 (ChemIDplus, GSRS) |






